3rd Circ. Doubts Jurisdiction In Generic-Fosamax Appeal

Law360, Philadelphia (December 18, 2013, 2:16 PM EST) -- The Third Circuit on Wednesday questioned whether it had jurisdiction to hear an appeal in a case that seeks to hold generic-drug manufacturers responsible for injuries allegedly caused by their versions of the bone drug Fosamax.

The 2011 ruling under appeal led to dismissal of the claims against most of the generic-Fosamax defendants, but it did not affect claims against Merck & Co., the original manufacturer of the drug.  

At the start of oral arguments, Judge Kent Jordan immediately interrupted the plaintiffs' attorney and inquired...
To view the full article, register now.

Related

Sections

Case Information

Case Title

In re: Fosamax Products


Case Number

12-2250

Court

Appellate - 3rd Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

June 22, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.